A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-α (PPAR-α) and PPAR-γ. Effect of PPAR-α activation on abnormal lipid metabolism in liver of Zucker fatty rats

Diabetes

Volumn 47, Issue 12, 1998, Pages 1841-1847

  Murakami, Koji ^a,c   Tobe, Kazuyuki ^a   Ide, Tomohiro ^c   Mochizuki, Toshiro ^c   Ohashi, Mitsuo ^c   Akanuma, Yasuo ^b   Yazaki, Yoshio ^a   Kadowaki, Takashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b INSTITUTE FOR ADULT DISEASES   (Japan)

^c KYORIN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 5 (2,4 DIOXO 5 THIAZOLIDINYLMETHYL) 2 METHOXY N [4 (TRIFLUOROMETHYL)BENZYL]BENZAMIDE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RECEPTOR SUBTYPE; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ISOTOPE LABELING; LIPID METABOLISM; LIPOGENESIS; LIVER METABOLISM; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; TRANSACTIVATION;

EID: 0031793850     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.12.1841     Document Type: Article

References (35)

1. Keller H, Wahli W: Peroxisome proliferator-activated receptors. Trends Endocrinol Metab 4:291-296, 1993
2. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W: Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology 137:354-366, 1996
3. Auboeuf D, Rieusset J, Fajas L, Vallier P, Frering V, Riou JP, Staels B, Auwerx J, Laville M, Vidal H: Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans: no alteration in adipose tissue of obese and NIDDM patients. Diabetes 46:1319-1327, 1997
4. Issemann I, Green S: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347:645-650, 1990
5. Gottlicher M, Demoz A, Svensson D, Tollet P, Berge RK, Gustafsson JA: Structural and metabolic requirements for activators of the peroxisome proliferator-activated receptor. Biochem Pharmacol 46:2177-2184, 1993
6. Eacho PI, Foxworthy PS: Inhibition of hepatic fatty acid oxidation by bezafibrate and bezafibroyl CoA. Biochem Biophys Res Commun 157:1148-1153, 1988
7. Kaikaus RM, Chan WK, Lysenko N, Ray R, Ortiz de Montellano PR, Bass NM: Induction of peroxisomal fatty acid β-oxidation and liver fatty acid-binding protein by peroxisome proliferators. J Biol Chem 268:9593-9603, 1993
8. Forman BM, Chen J, Evans RM: Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc Natl Acad Sci U S A 94:4312-4317, 1997
9. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPAR γ). J Biol Chem 270:12953-12956, 1995
10. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83:803-812, 1995
11. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10, 1996
12. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI: Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97:2859-2865, 1996
13. Rebrin K, Steil GM, Getty L, Bergman RN: Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038-1045, 1995
14. Hirose H, Lee YH, Inman LR, Nagasawa Y, Johnson JH, Unger RH: Defective fatty acid-mediated β-cell compensation in Zucker diabetic fatty rats. J Biol Chem 271:5633-5637, 1996
15. Triscari J, Greenwood MRC, Sullivan AC: Oxidation and ketogenesis in hepatocytes of lean and obese Zucker rats. Metabolism 31:223-228, 1982
16. Oussadou L, Griffaton G, Kalopissis A-D: Hepatic VLDL secretion of genetically obese Zucker rats is inhibited by a high-fat diet. Am J Physiol 271:E952-E964, 1996
17. Osumi T, Wen J-K, Hashimoto T: Two cis-acting regulatory sequences in the peroxisome proliferator-responsive enhancer region of rat acyl-CoA oxidase gene. Biochem Biophys Res Commun 175:866-871, 1991
18. Gulick T, Cresci S, Caira T, Moore DD, Kelly DP: The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci U S A 91:11012-11016, 1994
19. Rodriguez JC, Gil-Gomez G, Hegardt FG, Haro D: Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methyl- glutaryl-CoA synthase gene by fatty acids. J Biol Chem 269:18767-18772, 1994
20. Irikura T, Takagi K, Okada K, Yagasaki K: Reduction of fructose-induced hypertriglyceridemia and fatty liver in rats by 4-(4′-Chlorobenzyloxy)benzyl Nicotinate (KCD-232). Agric Biol Chem 48:977-983, 1984
21. de Duve C, Pressman BC, Gianetto R, Wattiaux R, Appelmans F: Tissue fractionation studies. Biochem J 59:604-617, 1955
22. Small GM, Burdett K, Connock MJ: A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase. Biochem J 227:205-210, 1985
23. Sher T, Yi H-F, McBride OW, Gonzalez FJ: cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 32:5598-5604, 1993
24. Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, Rodan GA: Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol Endocrinol 6:1634-1641, 1992
25. Elbrecht A, Chen Y, Cullinan CA, Hayes N, Leibowitz MD, Moller DE, Berger J: Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors γ 1 and γ 2. Biochem Biophys Res Commun 224:431-437, 1996
26. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM: Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358:771-774, 1992
27. Berry MN, Friend DS: High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 43:506-520, 1969
28. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, Lehmann JM: Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc Natl Acad Sci U S A 94:4318-4323, 1997
29. Fukuda H, Katsurada A, Iritani N: Nutritional and hormonal regulation of mRNA levels of lipogenic enzymes in primary cultures of rat hepatocytes. J Biochem 111:25-30, 1992
30. Lee SS-T, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H, Gonzalez FZ: Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferation. Mol Cell Biol 15:3012-3022, 1995
31. Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ: Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα). J Biol Chem 273:5678-5684, 1998
32. Spiegelman BM: PPAR-γ: adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507-514, 1998
33. Okuno A, Tamemoto H, Tobe K, Ueki K, Iwamoto K, Mori Y, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T: Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 101:1354-1361, 1998
34. Schoonjans K, Peinado-Onsurbe J, Lefebvre A-M, Heyman RA, Briggs M, Deeb S, Staels B, Auwerx J: PPARα and PPARγ activators direct tissue-specific transe optional response via a PPRE in the lipoprotein lipase gene. EMBO J 15:5336-5348, 1996
35. Lefebvre A-T, Peinado-Onsurbe J, Leitersdorf I, Briggs MR, Paterniti JR, Fruchart J-C, Fievet C, Auwerx J: Regulation of lipoprotein metabolism by thiazolidines occurs through a distinct but complementary mechanism relative to fibrates. Arterioscler Thromb Vasc Biol 17:1756-1764, 1997